Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2026-05-06 16:01:46 ET · period of report 2026-05-05 · accession 0001193125-26-208899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-06 16:01 | 2026-05-05 | FATE | EPSTEIN ROBERT S | Dir | M - OptEx | $1.69 | +25.0K | 36.3K | +221% | +$42.2K |
| D | 2026-05-06 16:01 | 2026-05-05 | FATE | EPSTEIN ROBERT S | Dir | M - OptEx | $0.00 | +25.0K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-05 | M | A | 25,000 | $1.69 | 36,331 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-05 | M | A | 25,000 | $0.00 | 0 | D | $1.69 · — to 2026-05-11 | 25,000 Common Stock | (F1) The shares subject to the option vested and became exercisable on the date of the 2017 Annual Meeting of Stockholders. |